Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

GT-160-246 as a promising approach to C. difficile colitis

Sep. 18, 2001

New HCV target discovered at Myriad Genetics, drug development program initiated

Sep. 10, 2001

Zeria licenses rights to Visicol from InKine

Sep. 10, 2001

Pariet receives E.U. clearance for treatment of symptomatic GERD

Sep. 7, 2001

Selective alpha4beta7 integrin inhibitors and their use described by Japanese lab

Sep. 6, 2001

Antiviral effect seen for rhIL-12 monotherapy in pilot trial in patients with chronic HCV

Sep. 6, 2001

Medivir and Chiron establish collaboration for novel HCV drugs

Sep. 5, 2001

Metabasis receives SBIR grant for hepatitis B prodrug development

Sep. 4, 2001

Sanofi-Synthelabo claims new series of beta3-adrenoceptor agonists

Sep. 3, 2001

JT describes new agents for hepatitis C

Sep. 3, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...